Safety Study of BMS-816336 in Healthy Male Subjects
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics
following single oral doses of BMS-816336 in healthy male subjects.